1. Home
  2. PLSE vs FSK Comparison

PLSE vs FSK Comparison

Compare PLSE & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$52.32

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

N/A

Current Price

$11.68

Market Cap

3.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSE
FSK
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
PLSE
FSK
Price
$52.32
$11.68
Analyst Decision
Strong Buy
Hold
Analyst Count
6
11
Target Price
★ $67.67
$12.13
AVG Volume (30 Days)
362.6K
★ 2.3M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 3.75%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$480.71
N/A
Revenue Next Year
$177.98
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$9.72
52 Week High
$58.94
$16.31

Technical Indicators

Market Signals
Indicator
PLSE
FSK
Relative Strength Index (RSI) 49.27 59.32
Support Level $49.66 $10.10
Resistance Level $56.54 $11.73
Average True Range (ATR) 4.03 0.35
MACD -0.08 0.10
Stochastic Oscillator 24.10 57.21

Price Performance

Historical Comparison
PLSE
FSK

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: